You are here » Home » Companies » Company Overview » Hester Biosciences Ltd

Hester Biosciences Ltd.

BSE: 524669 Sector: Health care
NSE: HESTERBIO ISIN Code: INE782E01017
BSE 00:00 | 30 Jul 2365.40 -15.10
(-0.63%)
OPEN

2410.00

HIGH

2420.00

LOW

2345.40

NSE 00:00 | 30 Jul 2368.85 -8.15
(-0.34%)
OPEN

2450.00

HIGH

2450.00

LOW

2342.65

OPEN 2410.00
PREVIOUS CLOSE 2380.50
VOLUME 1015
52-Week high 3180.00
52-Week low 1246.00
P/E 46.16
Mkt Cap.(Rs cr) 2,013
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 2410.00
CLOSE 2380.50
VOLUME 1015
52-Week high 3180.00
52-Week low 1246.00
P/E 46.16
Mkt Cap.(Rs cr) 2,013
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Hester Biosciences Ltd. (HESTERBIO) - Company History

Incorporated as a private limited company in Apr.'87 Hester Pharmaceutical (HPL) was converted into a public limited company in Nov.'93.HPL markets and distributes veterinary and pharmaceutical products like animal health products poultry vaccines poultry diagnostic laboratory kits and reagents. It markets the veterinary products of many international companies including Ghen Corporation Japan; Maine Biological Laboratories US; Idexx Corporation US; International Diagnostic Systems Corporation US; Biogal Galed Laboratories Israel; and Kemin Europa Belgium.The company's own production of veterinary vaccines (in Vials) is expected to commence soon. HPL has technical collaborations with Maine Biological Laboratories and Ghen Corporation.During 1996-97 company successfully implemented veterinary vaccine and commercial production has begun.The company has received licenses for producing 10 additional poultry vaccines.It has also signed an manufacturing agreement with Sinsui Inc for producing poultry vaccines.